Kasumi Yamamoto

发表

A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

Kazuhiro Suzuki, S. Yamaguchi, S. Nagao, 2020, Journal of Ovarian Research.

Successful Endoscopic Treatment for High-grade Cervical Intraepithelial Neoplasia with Gross Lesions of the Vagina

K. Yamamoto, S. Yamaguchi, S. Nagao, 2021, Gynecology and minimally invasive therapy.

Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma

Kazuhiro Suzuki, S. Yamaguchi, S. Nagao, 2021, International Journal of Clinical Oncology.

Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer

J. Kigawa, M. Shimada, K. Takehara, 2020, International Journal of Clinical Oncology.

Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy

Kazuhiro Suzuki, S. Yamaguchi, S. Nagao, 2020, International Journal of Clinical Oncology.

Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study

Masayuki Yoshida, E. Noguchi, T. Shimoi, 2022, BMC cancer.

Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review

T. Sudo, S. Yamaguchi, S. Nagao, 2015, International Journal of Gynecologic Cancer.

Comparison of Two PGMY PCR-Based HPV Genotyping Methods

I. Kukimoto, N. Yaegashi, T. Iwata, 2020 .

Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†.

H. Yoshikawa, K. Matsumoto, M. Shimada, 2022, Japanese journal of clinical oncology.

Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer.

Kazuhiro Suzuki, S. Yamaguchi, S. Nagao, 2019, Gynecologic oncology.

Placental mesenchymal dysplasia differentially diagnosed from molar pregnancy by 3‐D inversion mode rendering: A case report

M. Nakayama, Yuji Murata, K. Miura, 2014, The journal of obstetrics and gynaecology research.

Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study

T. Sudo, Kazuhiro Suzuki, S. Yamaguchi, 2019, International Journal of Clinical Oncology.

Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine.

I. Kukimoto, N. Yaegashi, T. Iwata, 2020, The Tohoku journal of experimental medicine.

Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program

H. Watari, N. Matsumura, K. Ushijima, 2019, Cancer science.

Treatment strategy for locally advanced squamous cell cervical cancer with clinically positive pelvic lymph nodes metastasis

Kazuhiro Suzuki, S. Yamaguchi, S. Nagao, 2021, The journal of obstetrics and gynaecology research.

Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan

N. Matsumura, H. Yoshikawa, N. Yaegashi, 2020, Cancer science.

Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women

H. Watari, N. Matsumura, H. Yoshikawa, 2022, Cancer science.

Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program

H. Yoshikawa, I. Kukimoto, N. Yaegashi, 2022, Vaccines.

Early impact of the Japanese immunization program implemented before the HPV vaccination crisis

K. Ushijima, H. Yoshikawa, N. Yaegashi, 2017, International journal of cancer.

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer

Masayuki Yoshida, E. Noguchi, T. Shimoi, 2023, Frontiers in Oncology.

Quality of life assessment of cell‐free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study

Kazuhiro Suzuki, S. Yamaguchi, S. Nagao, 2021, The journal of obstetrics and gynaecology research.

Grave outcome of granulocyte colony‐stimulating factor‐producing endometrial cancer: A case report and literature review

S. Mabuchi, M. Yamasaki, Yuji Murata, 2013, The journal of obstetrics and gynaecology research.

A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.

T. Sudo, S. Yamaguchi, S. Nagao, 2016, Japanese journal of clinical oncology.

Discordances in expression of human epidermal growth factor receptor 2 between primary and metastatic uterine carcinosarcoma: A proposal for HER2-targeted therapy specimen selection.

K. Yonemori, Tomoyasu Kato, T. Nishikawa, 2023, Annals of Diagnostic Pathology.

Correlation between pre-operative and final histological diagnosis on endometrial cancer

T. Sudo, Kazuhiro Suzuki, S. Yamaguchi, 2019, International Journal of Gynecologic Cancer.

Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy

E. Noguchi, T. Shimoi, K. Yonemori, 2023, Scientific reports.

Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy

Y. Ohe, Masayuki Yoshida, E. Noguchi, 2022, Breast Cancer Research and Treatment.

Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.

Kazuhiro Suzuki, S. Yamaguchi, S. Nagao, 2017, Gynecologic oncology.

Changes in HER3 expression profiles between primary and recurrent gynecological cancers

E. Noguchi, T. Shimoi, K. Yonemori, 2023, Cancer Cell International.

Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.

K. Yonemori, M. Ishikawa, Y. Kojima, 2023, Gynecologic oncology.